DalsnaFinance › IPOs › Bambusa Therapeutics › IPO
Bambusa Therapeutics, Inc. completed its initial public offering on Nasdaq on October 27, 2026, pricing at $16.00 a share.
| Ticker | BBTX |
|---|---|
| Exchange | Nasdaq |
| Status | Completed |
| Listing date | October 27, 2026 |
| Offering price | $16.00 |
| Sector | Biological Products, (No Diagnostic Substances) |
Bambusa Therapeutics, Inc. listed on Nasdaq on 2026-10-27.
Ingested from SEC EDGAR (424B4, 8-A12B), CIK 2044950.
Bambusa Therapeutics, Inc. — quote, profile and latest news →
Source: SEC EDGAR filings for Bambusa Therapeutics, Inc.. This page is general information, not investment advice.